Skip to content
Application 020822
- Type
- NDA
- Sponsor
- ALLERGAN
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 10MG BASE | Yes | No |
| 002 | CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 20MG BASE | Yes | No |
| 003 | CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 40MG BASE | Yes | Yes |
| 004 | CELEXA | CITALOPRAM HYDROBROMIDE | TABLET;ORAL | EQ 60MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0456-4010 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4010 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4010 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4010 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4010 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4020 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4020 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4020 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4020 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4020 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4040 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4040 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4040 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4040 | Celexa | citalopram | Allergan, Inc. | NDA | Current |
| 0456-4040 | Celexa | citalopram | Allergan, Inc. | NDA | Current |